Filtros de búsqueda

Lista de obras de

A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels

artículo científico publicado en 2020

Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer

artículo científico publicado en 2023

Extracellular Vesicle-Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General Toxicity

scientific article published on 15 January 2020

Mitochondrial copper depletion suppresses triple-negative breast cancer in mice

artículo científico publicado en 2020

Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

artículo científico publicado en 2010

Personalization of loco-regional care for primary breast cancer patients (part 1).

artículo científico publicado en 2015

Personalization of loco-regional care for primary breast cancer patients (part 2).

artículo científico publicado en 2015

Reducing the global breast cancer burden: the importance of patterns of care research

artículo científico publicado en 2005

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

artículo científico publicado en 2022

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda